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Abstract
Background&Aims: Sirtuin (SIRT1) is a NAD+-dependent protein deacetylase that regulates
hepatic lipid metabolism by modifying histones and transcription factors. Ethanol exposure
disrupts SIRT1 activity and contributes to alcoholic liver disease (ALD) in rodents, but the exact
pathogenic mechanism is not clear. We compared mice with liver-specific deletion of Sirt1
(Sirt1LKO) mice with their LOX littermates (controls).
Methods: We induced alcoholic liver injury in male Sirt1LKO and control mice, placing them on
Lieber-DeCarli ethanol-containing diets for 10 days and then administering a single dose of
ethanol (5 g/kg body weight) via gavage. Liver and serum samples were collected. We also
measured mRNA levels of SIRT1, SFRS10, and lipin-1β and lipin-1α in liver samples from
patients with alcoholic hepatitis (AH) and individuals without AH (controls).
Results: On the ethanol-containing diet, livers of Sirt1LKO mice accumulated larger amounts of
hepatic lipid and expressed higher levels of inflammatory cytokines than control mice; serum of
Sirt1LKO mice had increased levels of alanine aminotransferase and aspartate aminotransferase.
Hepatic deletion of SIRT1 exacerbated ethanol-mediated defects in lipid metabolism, mainly by
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altering the function of lipin-1, a transcriptional regulator of lipid metabolism. In cultured mouse
AML-12 hepatocytes, transgenic expression of SIRT1 prevented fat accumulation in response to
ethanol exposure, largely by reversing the aberrations in lipin-1 signaling induced by ethanol.
Liver samples from patients with AH had reduced levels of SIRT1 and a higher ratio of Lpin1β:α
mRNAs than controls.
Conclusions: In mice, hepatic deletion of Sirt1 promotes steatosis, inflammation, and fibrosis in
response to ethanol challenge. Ethanol-mediated impairment of hepatic SIRT1 signaling via
lipin-1 contributes to development of alcoholic steatosis and inflammation. Reagents designed to
increase SIRT1 regulation of lipin-1 might be developed to treat patients with alcoholic fatty liver
disease.
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Introduction
Alcoholic liver disease (ALD) is a major health problem in the United States and worldwide.
Considerable evidence demonstrates that ALD is associated with steatohepatitis as well as
more severe forms of liver injury such as fibrosis, cirrhosis, and hepatocellular cancer in
humans.1,2 Therefore, efforts to achieve a better understanding of alcoholic steatohepatitis
pathogenesis will facilitate development of novel therapeutic strategies.
Mammalian sirtuin (SIRT1) is a nicotinamide adenine dinucleotide (NAD+)-dependent class
III histone deacetylase (HDAC).3 The liver is one of the major organs in which SIRT1 plays
an essential role in the regulation of lipid metabolism via modification of the acetylation
status of a wide range of molecules including histones and transcriptional regulators such as
sterol regulatory element-binding protein 1 (SREBP-1), peroxisome proliferator-activated
receptor alpha (PPARα), PPAR co-factor (PGC-1α) or forkhead transcription factor O 1
(FoxO1).3 SIRT1 is able to either inhibit or stimulate the activities of these targets, thereby
regulating diverse lipid metabolism pathways including lipogenesis, fatty acid β-oxidation,
and lipoprotein uptake and secretion in liver. SIRT1 also exerts anti-inflammatory effects by
deacetylation of modified lysine residues on transcriptional regulators such as nuclear
transcription factor-κB (NF-κB), which is a master transcription factor involved in
regulation of pro-inflammatory cytokines.4 Growing evidence from human and rodent
studies shows that ALD and non-alcoholic fatty liver disease (NALD) are closely associated
with impairment of hepatic SIRT1 signaling.3-7 More importantly, genetic or
pharmacological stimulation of SIRT1 protects against both ALD and NALD in animals and
humans.3-7 Nevertheless, the causal role of SIRT1 in pathogenesis of ALD has yet to be
evaluated.
Lipin-1 is a protein that exhibits dual functions as an Mg2+-dependent phosphatidic acid
phosphohydrolase (PAP) in the triglyceride (TG) synthesis pathway and a transcriptional co-
activator to promote fat oxidation and suppress de novo lipogenesis.8,9 In the liver, lipin-1
has two major protein isoforms, lipin-1α (891 amino acids) and lipin-1β (924 amino acids),
derived from LPIN 1 alternative mRNA splicing.10-12 Lipin-1α and lipin-1β display
different subcellular localizations.10-12 In hepatocytes, lipin-1α is predominantly located in
the nucleus, whereas lipin-1β is exclusively located in the cytoplasm.13-14 The LPIN 1β
isoform is associated with increased expression of lipogenic genes, and excessive hepatic
lipid accumulation in animals.11,12 Accumulating evidence demonstrates that ethanol-
mediated aberrant lipin-1 signaling contributes to development of alcoholic steatosis in
rodents and humans.14-18 Our group found that ethanol significantly accentuates the
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cytoplasmic pro-lipogenic activity of lipin-1 whereas lipin-1 nuclear entry is attenuated by
chronic ethanol exposure in cultured hepatocytes or in mouse livers.14,18
The net consequence of these ethanol-mediated effects on lipin-1 localization is associated
with excessive fat accumulation in the liver. To date, there is little knowledge of how SIRT1
regulates lipin-1 signaling in liver. Our recent studies suggest that ethanol-mediated SIRT1
inhibition may alter acetylation/sumoylation status of lipin-1, thereby disrupting lipin-1
signaling in hepatocytes.14,18.
SFRS10 (official gene name, TRA2B), the homolog of Drosophila transformer-2 (Tra2),
belongs to the SR-like protein family of splicing factors.12 The alternatively spliced exon 6
of LPIN 1 contains a GGAA sequence motif that binds to SFRS10. Thus, SFRS10 emerges
as an important modulator of alternative splicing of LPIN 1.12 The effects of reduced
SFRS10 on LPIN1 splicing, favoring the LPIN1β isoform, are sufficient to increase
expression of lipogenic genes, activate lipogenesis and cause liver steatosis in mice.12 Of
note, SFRS10-mediated LPIN1 splicing is PAP-independent. SFRS10 is found to be down-
regulated in the fatty livers of high-fat fed mice as well as obese humans.12
In the present study, using hepatocyte-specific SIRT1 knockout (Sirt1LKO) mice and their
LOX littermates (WT), we have demonstrated for the first time that specific ablation of
hepatic SIRT1 in mice impairs lipin-1 signaling. Disruption of lipin-1 signaling results in
increased expression of genes encoding lipogenic enzymes, reduced expression of genes
encoding fatty acid oxidation enzymes, and ultimately leads to aggravated hepatic steatosis
and exacerbated inflammation in response to ethanol administration.
Materials and Methods
Mice
Hepatocyte-specific SIRT1 knockout (Sirt1LKO) mice were generated as described
previously.5 Briefly, the SIRT1 allele with floxed exon 4 was backcrossed into the C57BL/6
background. It was then bred with mice expressing the Cre recombinase driven by the
albumin promoter (Jackson laboratory) to generate Sirt1LKO in over 98% C57BL/6
background. Male Sirt1LKO mice and their age-matched littermate LOX controls (WT)
were fed ad libitum a standard laboratory chow diet.
Ethanol feeding Studies
A mouse model of chronic plus single binge ethanol consumption (referred as chronic-binge
model) was used as previously described.19,20 Ten to twelve week-old male Sirt1LKO mice
and their age-matched LOX littermate (WT) controls were divided into four dietary groups:
(1) WT control [low fat (LF) diet alone, 10% of calories as fat (6% cocoa butter and 4%
safflower oil)]; (2) WT plus ethanol (E; identical to the control LF diet but with 5% w/v
ethanol added); (3) Sirt1LKO control; (4) Sirt1LKO plus ethanol. All mice were first fed a
LF liquid control diet for 5 days. Ethanol groups were then fed a liquid diet containing 5%
w/v ethanol for 10 days while control mice were pair-fed to their ethanol fed counterparts
for 10 days. At day 11, mice in ethanol groups were gavaged a single dose of ethanol (5g/kg
body weight, 20% ethanol), while mice in control groups were gavaged an isocaloric dose of
dextrin maltose. The gavage was performed in the early morning, and mice had access to the
diets after alcohol gavage. The mice were euthanized and blood and tissue samples were
collected 9 h post-gavage. Liquid diets were freshly prepared from powder daily. For mice
on an ethanol-containing diet, animal cages were placed on heating pads to maintain body
temperature to prevent ethanol-induced hypothermia. Food intake was recorded daily.
During the entire feeding period, Sirt1LKO mice and their WT counterparts were observed
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to consume similar volumes of ethanol containing-diets. The studies were approved by the
Institutional Animal Care and Use Committee of University of South Florida.
Measurements of Hepatic Lactate, Pyruvate and Lipid Peroxidation
The concentrations of hepatic lactate and pyruvate were determined using deproteinized
liver samples with commercial kits from BioVision (Mountain View, CA).21 The lipid
peroxidation end-product, malondialdehyde (MDA), in liver was measured based on the
formation of thiobarbituric reactive substances and expressed as the extent of MDA
production.21
Statistical Analysis
Data are expressed as mean±SEM. Differences between groups were analyzed using a two-
tailed unpaired Student’s t-test (for human liver samples) or one-way analysis of variance
(ANOVA) test followed by the Newman–Keuls multiple ranges test, with a statistically
significant difference defined as a p value < 0.05.
Results
Hepatocyte-Specific Deletion of SIRT1 Alters Lipin-1 mRNA Splicing in Mice
We examined the function of SIRT1 in the liver utilizing hepatocyte-specific SIRT1
knockout (Sirt1LKO) mice on the C57BL/6 background. Consistent with previous findings,
Sirt1LKO mice were viable and phenotypically normal under a chow diet.5
We then examined whether SIRT1 is associated with lipin-1 signaling. Removal of hepatic
SIRT1 significantly induced mRNA expression levels of total lipin-1 and lipin-1β by nearly
2.5-fold, respectively, compared with the WT controls (Figure 1A and B). Accordingly, the
ratio of Lpin 1 β/α was increased by approximately 2-fold in the livers of Sirt1LKO mice
compared to WT controls (Figure 1B). Subsequent analysis revealed that both mRNA and
protein expression levels of SFRS10, a splicing factor that regulates lipin-1 mRNA
alternative splicing, were severely reduced in Sirt1LKO compared to WT controls (Figure
1C and D). Collectively, these data clearly demonstrate that hepatic SIRT1 deficiency
disturbs hepatic lipin-1 mRNA alternative splicing in mice.
Liver-Specific Deletion of SIRT1 Exacerbates Chronic-Binge Ethanol-Induced Fatty Liver
Injury in Mice
We investigated the role of SIRT1 on alcoholic fatty liver by pair-feeding WT and
Sirt1LKO mice using a chronic-binge ethanol feeding protocol (Supplementary Figure
1A).19,20 Mice were fed ethanol-containing diets for 10 days followed by a single gavage of
ethanol. Control mice were pair-fed control diets without ethanol for 10 days followed by a
single gavage of maltose.
Chronic-binge ethanol significantly increased liver weight to body weight ratio, liver
triglyceride, cholesterol and caused mild liver steatosis in WT mice compared with pair-fed
WT controls (Figure 2 and Supplementary Table I). Ethanol feeding caused significantly
higher immunohistochemical staining of F4/80+, a marker of liver inflammation, in the
livers of WT mice compared to WT controls (Figure 2C and F). Interestingly, the serum
AST or ALT levels were significantly but mildly elevated in the ethanol-fed WT mice
compared to WT controls (Supplementary Figure 1B and C). It has been reported that
plasma ALT levels in mice were substantially elevated in response to chronic-binge ethanol
challenge.19,20 This discrepancy may be due to the fact that a low fat diet was used in our
study.21
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Ethanol administration exacerbated the development of liver injury in Sirt1LKO mice
compared to WT mice, as indicated by augmented liver weight to body weight ratio,
markedly enhanced hepatic triglyceride and cholesterol contents, significantly elevated
serum ALT and AST levels, and substantially enhanced the levels of F4/80+ staining in the
livers of ethanol-fed Sirt1LKO mice compared with the livers of ethanol-fed WT mice
(Figure 2 and Supplementary Table 1).
Immunohistochemical staining for Sirius red, α-SMA and collagen revealed higher levels of
those indicators of liver fibrosis in the livers of ethanol-fed Sirt1LKO mice compared with
the livers of ethanol-fed WT mice (Figure 3 and Figure 4A). Accordingly, ethanol feeding
increased the hydroxyproline content and α-SMA levels in Sirt1LKO mice compared to all
other groups (Figure 2D). Moreover, the mRNA expression of early markers of hepatic
fibrosis such as collagen I, tissue inhibitor of metalloproteinase 1 (Timp-1), or transforming
growth factor beta 1 (TGF-β) was augmented in ethanol-fed Sirt1LKO mice compared to
ethanol-fed WT mice (Figure 4B). The mRNA levels of fibronectin were significantly
increased in ethanol-fed WT and in Sirt1LKO mice with or without receiving ethanol when
compared to controls, whereas CD65 mRNA levels were unchanged in all of the groups
(Supplementary Figure 2). These results suggest that ethanol-fed Sirt1LKO mice partially
progressed from fatty liver to mild fibrotic liver.
Taken together, our data clearly demonstrate that liver-specific removal of SIRT1
exacerbates the development of alcoholic fatty liver injury in mice.
Hepatocyte-Specific Deletion of SIRT1 Drastically Exacerbates Oxidative Stress and
Promotes the Inflammatory Responses in Mice Fed Ethanol
Analysis of mRNA from livers of Sirt1LKO mice revealed a significant increase in
macrophage markers such as macrophage inflammation protein (MIP-1α) and F4/80+, and
the macrophage markers were further increased in ethanol-fed Sirt1LKO mice
(Supplementary Figure 3A). Accordingly, the mRNA levels of pro-inflammatory cytokines
including tumor necrosis factor-alpha (TNF-α) and monocyte chemoattractant protein 1
(MCP-1), two prominent pro-inflammatory cytokines involved in pathogenesis of ALD,
were significantly higher in the livers of Sirt1LKO mice fed with or without ethanol
compared to WT mice, supporting the role of SIRT1 as a anti-inflammatory regulator
(Supplementary Figure 3A).3,4 Consistently, the semi-quantification of histological
inflammation showed that removal of hepatic SIRT1 promoted the liver inflammatory
responses in ethanol-fed mice (Supplementary Figure 3C).
Interestingly, ethanol feeding dramatically increased the mRNA levels of two pro-
inflammatory molecules, lipocaline-2 (Lcn-2) and serum amyloid A-1 (SAA-1), in the livers
of WT controls and Sirt1LKO mice compared to their respective controls, suggesting
involvement of both SIRT1-dependent and SIRT1-independent inflammatory mechanisms
(Supplementary Figure 3B). Note that rremoval of hepatic SIRT1 significantly increased
SAA1 mRNA levels in the absence of ethanol.
SIRT1 ablation mildly but significantly generates oxidative stress, as demonstrated by the
slight increase in hepatic malondialdehyde (MDA), a lipid peroxidation end-product,
compared to WT controls (Supplementary Table I). However, ethanol feeding to Sirt1LKO
mice drastically increased MDA levels approximately 5-fold compared with all other
groups, demonstrating that oxidative stress is drastically exacerbated in response to ethanol
administration in Sirt1LKO mice.
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Removal of Hepatic SIRT1 Promotes Ethanol-Mediated Impairment of Lipin-1 Signaling in
Mice
We examined the involvement of lipin-1 signaling in exacerbated alcoholic fatty liver injury
in Sirt1LKO mice. WT mice fed with ethanol or Sirt1LKO mice fed with a control diet
slightly but significantly reduced the mRNA levels of hepatic lipin-1α whereas lipin-1β
mRNA expression levels were increased in those mice compared to WT controls
(Supplementary Figure 4A). As a result, the ratio of Lpin1 β/α in the livers of ethanol-fed
WT mice or Sirt1LKO mice was significantly elevated compared to WT controls (Figure
4C). More importantly, hepatic SIRT1 deficiency significantly augmented the ethanol-
mediated increase of Lpin 1 β/α compared to all other groups (Figure 4C). Ethanol
administration significantly inhibited mRNA and protein levels of SFRS10 in WT mice
compared to WT controls (Figure 4D and Supplementary Figure 4B). Ethanol-mediated
SFRS10 inhibition was further slightly but significantly augmented in the livers of ethanol-
fed Sirt1LKO mice compared with all other groups (Figure 4D and Supplementary Figure
4B).
Nucleocytoplasmic shutting of lipin-1 regulates its function as a transcriptional co-
activator.8-14, 22-24 Ethanol-fed WT mice or Sirt1LKO mice displayed a markedly increased
amount of lipin-1 in the cytoplasm whereas the amount of nuclear lipin-1 was significantly
reduced in those mice (Figure 4E and Supplementary Figure 4C). Ethanol-mediated lipin-1
nucleocytoplasmic shuttling was greatly augmented in the Sirt1LKO mice compared to all
other groups (Figure 4E and Supplementary Figure 4C). These data demonstrate that ethanol
feeding exacerbates impairment of hepatic lipin-1 signaling in Sirt1LKO mice.
Hepatic-Specific Removal of SIRT1 Exacerbated Ethanol-Mediated Abnormalities in
Hepatic Lipid Metabolism Pathways in Mice
Ethanol-mediated SIRT1 inhibition activates SREBP-1.21,25 As such, we investigated
whether SIRT1 deficiency exacerbates ethanol's stimulation of SREBP-1 signaling. Indeed,
the amount of active, nuclear form of SREBP-1 (nSREBP-1c) protein was highest in the
livers of ethanol-fed Sirt1LKO mice compared to all other groups (Supplementary Figure
5A and B). Immunofluorescent staining for SREBP-1 (green) and DAPI (blue) further
confirmed these findings (Supplementary Figure 5C). Additionally, ethanol feeding
significantly increased hepatic mRNA expression levels of lipogenic enzymes including
SREBP-1c, fatty acid synthase (FAS), stearoyl-coenzyme A desaturase 1 (SCD1) and ACC
where these increases were more pronounced in ethanol-fed Sirt1LKO mice (Supplementary
Figure 5D).
Ethanol impairs PGC-1α signaling via SIRT1.21 While ethanol significantly reduced mRNA
or protein expression of PGC-1α in WT mice, PGC-1α expression levels was further
suppressed in the livers of ethanol-fed Sirt1LKO mice (Supplementary Figure 6A and B).
Accordingly, SIRT1 ablation further suppressed the mRNA expression levels of several
PGC-1α-regulated enzymes involved in fatty acid oxidation, including PPARα, carnitine
palmitoyltransferase 1a (CPT1a), acyl-CoA oxidase (AOX), and CD36, to levels
significantly lower than all other groups (Supplementary Figure 6C).
It is worthwhile to note that ethanol administration to Sirt1LKO mice substantially increased
PPARγ mRNA levels compared to all other groups, suggesting that PPARγ also contributes,
at least in part, to aggravated alcohol-induced liver steatosis in Sirt1LKO mice
(Supplementary Figure 6C). Taken together, our data suggest that removal of hepatic SIRT1
in mice exacerbates ethanol-mediated abnormalities in hepatic lipid metabolism.
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Ethanol Feeding Promotes Nucleocytoplasmic Shuttling of NFATc4 and Aggravates ER
Stress in the Livers of SIRT1LKO Mice
Lipin-1 regulates nuclear factor of activated T cells c4 (NFATc4), an important
inflammatory factor.26 As shown in Figure 5A and B, in comparison with all other groups,
ethanol administration to Sirt1LKO mice robustly induced nuclear accumulation of NFATc4
and significantly decreased the amount of NFATc4 in the cytoplasm, suggesting that
exacerbated inflammation in the livers of ethanol-fed Sirt1LKO mice may be mediated, at
least in part, by impairment of the hepatic SIRT1-lipin-1-NFATc4 axis.
Roles for hepatic excessive fat accumulation, inflammation and oxidative stress are all
linked to endoplasmic reticulum (ER) stress in the etiology of alcoholic stestohepatistis.1,2,27
Indeed, XBP-1 mRNA splicing was significantly enhanced in the livers of Sirt1LKO mice
fed with or without ethanol compared to WT controls (Supplementary Figure 7).
Consistently, significantly increased mRNA of CHOP was detected in ethanol-fed WT or
Sirt1LKO mice compared to WT controls (Supplementary Figure 8A). More importantly,
the mRNA expression levels of XBP-1 and CHOP were greatly increased in ethanol-fed
Sirt1LKO mice compared to all other groups. Accordingly, increased Bip levels,
phosphorylation of JNK (p-JNK) and total JNK expression were significantly augmented in
the livers of ethanol-fed Sirt1LKO mice compared to other groups (Supplementary Figure
8B-D). Together, these findings demonstrate that aggravated liver injury in Sirt1LKO results
in elevated ER stress in the liver in response to ethanol challenge.
Ethanol Metabolism Perturbs Lpin 1 Alternative Splicing Via SFRS10 Inhibition in AML-12
Hepatocytes
We dissected the mechanisms by which ethanol exposure disturbs hepatic lipin-1 signaling
using cultured AML-12 hepatocytes. Consistent with in vivo animal studies, the mRNA
levels of SFRS10 in AML-12 cells treated with ethanol were significantly lower than
controls (Figure 5C). Furthermore, mRNA expression levels of lipin-1β were up-regulated in
AML-12 cells exposed to ethanol compared to controls, whereas lipin-1α mRNA expression
levels were significantly inhibited by ethanol exposure (Figure 5C). As a result, the Lpin 1 β/
α ratio was significantly increased in response to ethanol exposure compared to controls
(Figure 5D).
Hepatic ethanol metabolizes via class I (low Km) alcohol dehydrogenase (ADH) and
aldehyde dehydrogenase 2 (ALDH2) proteins in AML-12 hepatocytes.14,18 Treatment with
either 4-methylpyrazole (an ADH inhibitor) or cyanamide (an ALDH2 inhibitor) blocked the
ability of ethanol to interfere with lipin-1 signaling, indicating that ethanol regulates lipin-1
mRNA alternative splicing via its metabolism (Figure 5C and D).
We further investigated whether ethanol-induced aberrant lipin-1 signaling is mediated
through inhibition of the SIRT1-SFRS10 axis using a cellular alcoholic steatosis model.
Incubation of AML-12 hepatocytes with ethanol increased intracellular lipid accumulation
(Supplementary Figure 9 and Figure 10A). This lipid accumulation was largely reversed
when AML-12 cells were transfected with SIRT1wt or SFRS10wt. Conversely,
overexpression of SIRT1H363Y, SIRT1siRNA or SFRS10siRNA significantly augmented
the TG levels in AML-12 hepatocytes (Supplementary Figure 9 and Figure 10A).
Accordingly, co-transfection SIRT1wt or SFRS10wt largely blocked the ability of ethanol to
disturb the Lpin 1β/α axis (Supplementary Figure 10B and Figure 11). These SIRT1- or
SFRS10-medaited protective effects were not seen when SIRT1 or SFRS10 was inhibited by
SIRT1H363Y, SIRT1siRNA or SFRS10siRNA (Supplementary Figure 11). Our data
demonstrate that increased Lpin 1β/α ratio by ethanol is mediated, at least in part, through
SIRT1-SFRS10 inhibition in hepatocytes.
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Impairment of SIRT1-SFRS10-Lpin 1β/α Axis in the Livers of Patients with Alcoholic
Hepatitis
To investigate the clinical relevance of SIRT1-SFRS10-Lpin1 β/α axis in the pathogenesis
of ALD, we examined mRNA expression levels of SIRT1, SFRS10 and Lpin1 β/α in liver
samples from patients with alcoholic hepatitis (AH).28-31
Remarkably, SIRT1 mRNA levels were severely decreased in the livers of patients with AH
compared to the normal controls (Figure 6A). The hepatic lipin-1α mRNA levels were
significantly lower in patients with AH whereas lipin-1β mRNA expression was not
significantly altered in the livers of AH compared to controls. As a result, the ratio of
hepatic Lpin1 β/α in the livers of patients with AH was modestly but significantly elevated
(Figure 6C). The hepatic mRNA levels of SFRS10 were indeed reduced in patients with AH
but did not reach statistical significance compared to controls (Figure 6B). Collectively, our
data clearly suggest that impairments of the SIRT1-SFRS10-Lpin 1β/α axis may contribute,
at least in part, to the development of human ALD such as AH.
Discussion
In the present study, utilizing a murine model of chronic-binge ethanol feeding, we clearly
demonstrated that genetic ablation of hepatic SIRT1 is associated with the rapid onset and
progression of steatosis, inflammation, and fibrosis in response to ethanol challenge
compared to WT control mice. We found that ethanol administration to Sirt1LKO mice
disrupted lipin-1 signaling, resulting in exacerbated abnormalities in hepatic lipid
metabolism which eventually leads to steatosis and inflammation in the liver. Additional
mechanistic studies revealed that ethanol metabolism specifically disturbed Lpin1 β/α ratio,
largely via SIRT1-SFRS10 inhibition, which results in steatosis in AML-12 hepatocytes.
Consistently, the SIRT1-SFRS10-Lpin 1β/α axis was perturbed in the livers from patients
with AH. Altogether, our novel findings demonstrate that loss of hepatic SIRT1 aggravates
alcoholic steatohepatitis in whole or in part via disrupting lipin-1 signaling in mice (Figure
7).
The present study suggests that hepatic SIRT1-lipin-1 axis represents a major signaling
route in ethanol-induced steatosis in hepatocytes and in mice. In recent years, several
important transcriptional regulators such as SIRT1, SREBP-1, and PGC-1α have been
identified as specific targets of ethanol action in the liver.1,14,18,21,22 Among those
molecules, SIRT1 appears to be the most upstream signaling molecule targeted by ethanol in
liver. However, the central issue of how ethanol-mediated impairment of SIRT1 leads to
subsequent liver steatosis and inflammation is not completely understood. We provide
evidence suggesting that lipin-1 is a vital downstream regulator that may be responsible for
ethanol-mediated impairment of a hepatic signaling network controlled by SIRT1, and
ultimately that dysregulation of this pathway leads to development of steatosis and
inflammation in liver.
Lipin-1 mRNA alternative splicing is regulated by SFRS10.12 Reduced SFRS10 alters the
generation of LPIN1 splice isoforms, yielding an increase in the β isoform in parallel with a
decrease in the α isoform. However, how hepatic SFRS10 is regulated is largely unknown.
Our study, for the first time to the best of our knowledge, demonstrates the interplay
between SIRT1 and SFRS10. However, the precise mechanism by which SIRT1 regulates
SFRS10 gene and protein expression remains to be elucidated. Our data imply that SIRT1
up-regulates SFRS10 at multiple levels, including transcriptional and post-transcriptional
levels. It is possible that SIRT1 increases SFRS10 mRNA stability leading to elevated
SFRS10 mRNA and subsequently protein levels. Moreover, a recent study demonstrates that
SIRT1 up-regulates the H3K9me3 methyltransferase Suv39h1 via increasing its half-life
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through inhibition of Suv39h1 lysine 87 polyubiquitination by the E3-ubiquitin ligase
MDM2.32 Therefore, it is logical to speculate that SIRT1 may physically interact with the
SFRS10 protein and modulate the acetylation status of SFRS10 which prevents proteasomal
degradation of SFRS10 and subsequently stabilizes and increases SFRS10 protein
expression levels in hepatocytes. Surprisingly, we found that the changes in mRNA levels of
lipin-1α or SFRS10 in liver samples from patients with AH were modest, suggesting that
gene expression of SFRS10 or lpin1 β/α in the livers of patients with AH may correlate with
liver disease severity. Further studies may be needed to evaluate if the findings obtained in
these patients with severe AH are also found in the livers with mild to moderate fatty liver
injury.
We found that ethanol-mediated inhibition of SIRT1 leads to reduced SFRS10 gene and
protein expression levels in hepatocytes. On the other hand, ethanol may directly down-
regulate SFRS10. Ethanol metabolism via ADH and ALDH2 are required for the inhibitory
effect of ethanol on SFRS10 in cultured hepatocytes. Hepatic ethanol metabolism is known
to causes a shift in redox state and generates oxidative stress in hepatocytes.1 Therefore, it is
possible that SFSR10 is inhibited due to an altered redox state or excessive reactive oxygen
species production in hepatocytes exposed to ethanol. The exact mechanism by which
ethanol disrupts hepatic SFRS10-Lpin 1 β/α axis merits further investigation.
In addition to the SIRT1-SFRS10-Lpin 1 β/α axis, ethanol likely affects lipin-1 at multiple
levels. For instance, we have recently reported that chronic ethanol administration affects
acetylation/SUMOylation modifications of lipin-1 and that alteration of these modifications
subsequently disturbs lipin-1 signaling in mouse livers.18,33 Therefore, ethanol-mediated
SIRT1 inhibition may directly influence acetylation/SUMOylation modifications of lipin-1.
Moreover, the impaired SIRT1-lipin-1 signaling can not be solely responsible for alcoholic
steatosis. In hepatocytes, SIRT1 interacts with PPARα and is required to activate PGC-1α to
induce fatty acid oxidation enzymes.3-5 Ethanol-mediated SIRT1 inhibition may directly
perturb PGC-1α/PPAR signaling.1,2 Interestingly, nuclear lipin-1 functions as a
transcriptional co-activator by interacting with PGC-1α/PPARα.34 Impaired function of the
SIRT1-lipin-1 axis in alcoholic steatosis may lead to inhibited PGC-1α/PPARα, and
subsequent incomplete activation of its target genes encoding fatty acid oxidation enzymes.
It is intriguing that removal of SIRT1 in the livers of mice slightly affects AMP-activated
kinase (AMPK) and miR-217, two known regulators of SIRT1 (Supplementary Figure 12A
and B).14,21 Interestingly, AMPK activity was inhibited in both WT and Sirt1LKO mice
receiving ethanol to the same extent. Ethanol feeding also did not further elevate hepatic
miR-217 levels compared to WT mice. These findings suggest that the aggravated
steatohepatitis in ethanol-fed Sirt1LKO mice may be regulated in an AMPK- or miR-217-
independent manner.
The augmented inflammatory response in ethanol-fed Sirt1LKO mice is likely due to
increased hepatic fat accumulation and elevated ER stress. Interestingly, we have recently
observed that liver specific-deletion of lipin-1 in mice led to the exacerbated inflammatory
response via activation of NF-κB and NFATc4, two vital inflammatory regulators (M.You,
preliminary observations). It is possible that ethanol-mediated disruption of SIRT-lipin-1 via
NFATc4 signaling is partially responsible for the inflammatory response observed in the
livers of ethanol-fed Sirt1LKO mice. The role of the SIRT1-lipin-1 axis in ethanol-mediated
hepatic inflammation is currently under investigation in our laboratory.
In summary, we have presented novel evidence that ethanol-mediated impairment of SIRT1-
lipin-1 signaling is crucial in the development of alcoholic steatohepatitis in mice. Our
findings further highlight the SIRT1-SFRS10-Lpin 1 β/α axis as a major signaling route in
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the pathogenesis of alcoholic liver disease. These findings suggest that nutritional or
pharmacological modulation of SIRT1-SFRS10-Lpin1 β/α could be potential therapeutic
approaches for treating human alcoholic steaotohepatitis.
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Figure 1. Liver-specific deletion of SIRT1 alters lipin-1 signaling in mice
Sirt1LKO (LKO) and LOX littermates (WT) mice were fed chow diets. (A) Relative liver
mRNA levels of total (T) lipin-1, lipin-1α, lipin-1β, and SFRS10. (B) Hepatic Lpin-1β/α
ratio. (C) Representative Western analysis of SFRS10 protein expression levels. (D)
Relative SFRS10 protein levels. Results are expressed as mean ± SEM (n=4-8 mice). Means
without a common letter differ, p< 0.05.
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Figure 2. Liver-specific deletion of SIRT1 aggravates alcoholic fatty liver in mice
Sirt1LKO (LKO) mice were fed chronically ethanol containing diets for 10 days followed
by single gavage of ethanol. WT Control mice were pair-fed control diets without ethanol
for 10 days followed by single gavage of maltose. (A) Pictures of mouse livers. (B)
Hematoxylin and eosin (H&E) staining (original magnification×40) of liver sections. (C)
Immunohistochemical staining for F4/80+ (original magnification×40). (D) Hepatic
triglyceride (TG) levels. (E) Hepatic cholesterol levels. (F) Relative levels of F4/80+
staining. Results are expressed as mean ± SEM (n=4-8 mice). Means without a common
letter differ, p< 0.05.
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Figure 3. Liver-specific deletion of SIRT1 causes liver fibrosis in ethanol-fed mice
Mice were fed as described in Fig.2. (A) Sirius red staining (original magnification×40). (B)
Relative hepatic levels of Sirius red staining. (C) Immunohistochemical staining for α-SMA
(original magnification×40). (D) Relative hepatic levels of α-SMA staining. (E) Hepatic
hydroxyproline levels. (F) Western analysis of hepatic α-SMA protein expression levels.
Results are expressed as mean ± SEM (n=4-8 mice). Means without a common letter differ,
p< 0.05.
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Figure 4. Liver-specific deletion of SIRT1 promotes ethanol-mediated impairment of lipin-1
signaling in mice
Mice were fed as described in Fig. 2. (A) Relative levels of α-SMA staining. (B) Relative
hepatic mRNA levels of Collagen1α, Timp-1, and TGF-β. (C) Hepatic Lpin-1β/α ratio. (D)
Representative Western analysis of hepatic SFRS10 protein expression levels. (E)
Representative western blotting analysis of the lipin-1 protein expression levels in nucleus
(Nuc) or cytoplasm (Cyto) of mice fed a control or ethanol diet. All data are expressed as
mean ± SEM (n =3-8 animals). Means without a common letter differ, p < 0.05.
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Figure 5. Liver-specific deletion of SIRT1 promotes ethanol-induced nucleocytoplasmic shuttling
of NFATc4 in mice
Mice were fed as described in Fig. 2. (A) Representative western blotting analysis of the
NFATc4 protein expression levels in nucleus (Nuc) or cytoplasm (Cyto) of mice fed a
control or ethanol diet. (B) Relative hepatic NFATc4 protein levels. (C) AML-12 cells were
treated with ethanol (50 mM) in the presence or absence of 4-methylpyrazole (4-MP) (0.1
mM), cyanamide (Cya) (0.1 mM) for 48 h. Relative mRNA levels of total lipin-1, lipin-1α,
lipin-1β, and SFRS10. (D) Lpin1 β/α ratio. Results are expressed as mean ± SEM (n=3-6
mice). All in vitro data are from at least 3 experiments. Means without a common letter
differ, p< 0.05.
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Figure 6. Hepatic mRNA levels of SIRT1, lpin1β/α, SFRS10 from patients with alcoholic
hepatitis
Real-time PCR analyses of liver tissues from normal livers (n=6) and patients with alcoholic
hepatitis (AH) (n=34). (A) Relative mRNA levels of SIRT1. (B) Hepatic ratio of Lpin1 β/α.
(C) Relative mRNA levels of lipin-1α, lipin-1β and SFRS10. All data are expressed as mean
± SEM (normal liver, n=3; AH, n=34). ***p<0.001.
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Proposed role of SIRT1-lipin-1 signaling in the development of alcoholic steatohepatitis
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